No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
NVAX Novavax
- 4.930
- +0.220+4.67%
Close May 3 16:00 ET
- 4.930
- 0.000-0.01%
Pre 08:11 ET
692.18MMarket Cap-911P/E (TTM)
4.940High4.690Low4.67MVolume4.840Open4.710Pre Close22.58MTurnover3.76%Turnover RatioLossP/E (Static)140.40MShares10.30052wk High-0.97P/B612.06MFloat Cap3.53252wk Low--Dividend TTM124.15MShs Float331.680Historical High--Div YieldTTM5.32%Amplitude3.532Historical Low4.836Avg Price1Lot Size
Pre-Market
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Express News | Novavax Shares Down 1.8% Premarket After Investor Shah Capital Urges Stockholders to Vote Against Election of Three Directors
Express News | Shah Capital Management: Firmly Believe That "Novavax Is Undervalued"
Express News | Shah Capital Management: Intends to Vote Against Election of Richard H Douglas, Margaret G Mcglynn, David Mott as Class II Directors at Novavax AGM
Earnings Week Ahead: Disney, Palantir, Shopify, Uber, Plug Power and More
How Is The Market Feeling About Novavax?
Novavax's (NYSE:NVAX) short percent of float has fallen 8.76% since its last report. The company recently reported that it has 43.91 million shares sold short, which is 36.57% of all regular shares th
Novavax (NVAX) Increases Despite Market Slip: Here's What You Need to Know
Comments
$Novavax(NVAX.US$ $Moderna(MRNA.US$
April 18, 2024
For Global Investor Audience Only
Novavax’s Nuvaxovid XBB.1.5 dispersion for injection, COVID-19 Vaccine (recombinant, adjuvanted) (NVX-CoV2601) is now available to pharmacies across the United Kingdom (U.K.) for private healthcare providers to offer an updated protein-based non-mRNA option as part of the 2024 vaccination season.
To...
April 18, 2024
For Global Investor Audience Only
Novavax’s Nuvaxovid XBB.1.5 dispersion for injection, COVID-19 Vaccine (recombinant, adjuvanted) (NVX-CoV2601) is now available to pharmacies across the United Kingdom (U.K.) for private healthcare providers to offer an updated protein-based non-mRNA option as part of the 2024 vaccination season.
To...
1
$Novavax(NVAX.US$ Novavax And Fujifulm Entered Confidential Settlement Agreement And Release; Pursuant To Settlement, Co. Paid $42M To Fujifilm
1
5
is tome to buy or to hold for this sdog?🏆🫶🏼🤩🎰👍
1
2
HC Wainwright & Co. Maintains "Buy" Rating on Novavax, Lowers Price Target to $19.
In the dynamic world of biotechnology, Novavax, Inc. (NASDAQ: NVAX) remains a company to watch, despite recent adjustments in its price target by HC Wainwright & Co. The investment firm recently maintained its "Buy" rating on Novavax but lowered the price target from its previous estimate to $19. This development has stirred discussions among invest...
In the dynamic world of biotechnology, Novavax, Inc. (NASDAQ: NVAX) remains a company to watch, despite recent adjustments in its price target by HC Wainwright & Co. The investment firm recently maintained its "Buy" rating on Novavax but lowered the price target from its previous estimate to $19. This development has stirred discussions among invest...
2
$Novavax(NVAX.US$ I like to buy all the most heavily shorted stocks. The finviz screener is awesome!
2
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg